Answers are grounded in this paper and cite their sources.
Background: Lactate dehydrogenase (LDH) and D-dimer are biomarkers associated with tissue injury and coagulation activation in COVID-19. This study assessed LDH activity and D-dimer levels among patients hospitalised with COVID-19 at Treichville University Hospital, Côte d’Ivoire. Methods: A descriptive and analytical cross-sectional study was conducted from 14 March to 23 July 2020 among 60 adult patients with confirmed SARS-CoV-2 infection admitted to the Infectious and Tropical Diseases Department. LDH activity and D-dimer levels were measured using a Roche cobas c311 automated analyser. Quantitative variables were summarised as means ± standard deviations, categorical variables as frequencies and percentages, and statistical significance was set at p < 0.05. Results: Men represented 56.67% of participants (34/60) and women 43.33% (26/60). Elevated LDH activity (>225 IU/L) was observed in 30/34 men (88.24%) and 25/26 women (96.15%), corresponding to 55/60 patients (91.67%). Overall, mean LDH activity was 56.50 ± 27.58 IU/L in the low group (n = 2), 192.67 ± 44.06 IU/L in the normal group (n = 3), and 544.13 ± 220.79 IU/L in the elevated group (n = 55). Elevated D-dimer concentrations were reported in 25/34 men (73.5%) and 23/26 women (88.5%). Conclusion: Elevated LDH activity and D-dimer concentrations were frequent among patients hospitalised with COVID-19. These descriptive findings warrant further investigation; the cross-sectional design and limited subgroup sizes do not support prognostic conclusions.
No takes yet. Share an insight, caveat, or question.
Philippe et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: